Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 22246-18-0
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
22246-18-0 |
Appearance :: |
White Powder |
Molecular Formula:: |
C9H9NO2 |
Molecular Weight:: |
163.173 |
EINECS NO:: |
606-966-5 |
MDL NO:: |
MFCD06410891 |
CAS NO:: |
22246-18-0 |
Appearance :: |
White Powder |
Molecular Formula:: |
C9H9NO2 |
Molecular Weight:: |
163.173 |
EINECS NO:: |
606-966-5 |
MDL NO:: |
MFCD06410891 |
Product Description:
Product Name: 3,4-Dihydro-7-hydroxy-2(1H)-quinolinone CAS NO: 22246-18-0
Synonyms:
3,4-Dihydro-7-hydroxycarbostyril;
7-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline;
7-Hydroxy-3,4-dihydro-2(1H)-quinolinone;
7-Hydroxy-3,4-dihydro-quinolin-2-one;
7-hydroxy-3,4-dihydro-2-quinolinone;
7-Hydroxy-3,4-dihydro carbostyril;
Chemical & Physical Properties:
Appearance :White powder
Assay :≥99.0%
Density:1.282 g/cm3
Boiling Point:403.7℃ at 760 mmHg
Melting Point:233-237℃
Flash Point:198℃
7-Hydroxy-3,4-dihydroquinolin-2(1H)-one is an Aripiprazole intermediate.
Aripiprazole, as a kind of psychosuppressive drugs, is mainly used for the treatment of schizophrenia. In rare cases, it may be related to the fatal neuroleptic malignant syndrome (NMS), and it is also related to delayed dyskinesia (TD). Research shows that atypical antipsychotic drugs may cause hyperglycemia. Although this study did not examine aripiprazole, the relationship between aripiprazole and hyperglycemia is still uncertain. Therefore, patients should be treated during treatment Perform blood glucose monitoring.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
